Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LPL | P06858 | 7/20 | 0.33 |
| ▸ | LIPG | Q9Y5X9 | 7/20 | 0.33 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | DAO | P14920 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | USP30 | Q70CQ3 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL824177 | 0.82 | JAK2 (0.32) | LPLLIPGP2RX7 | |
| SCHEMBL28519289 | 0.80 | DAO (0.36) | LPLLIPGP2RX7DAOMAPK1 | |
| SCHEMBL1829293 | 0.78 | LPL (0.35) | LPLLIPGP2RX7MAPK1USP30 | |
| SCHEMBL31387250 | 0.78 | ESR2 (0.31) | — | |
| SCHEMBL1830220 | 0.75 | LPL (0.35) | LPLLIPGP2RX7MAPK1USP30 | |
| SCHEMBL11928934 | 0.75 | LPL (0.31) | LPLLIPGP2RX7 | |
| SCHEMBL24759504 | 0.73 | ALDH1A1 (0.37) | KDM4EMEN1ALDH1A1MAPTKMT2A | |
| SCHEMBL28559742 | 0.73 | KDM4E (0.37) | KDM4EMEN1ALDH1A1MAPTKMT2A | |
| SCHEMBL13721705 | 0.73 | MAPK1 (0.34) | LPLLIPGP2RX7MAPK1USP30 | |
| SCHEMBL10053904 | 0.73 | LPL (0.32) | LPLLIPGP2RX7MAPK1USP30 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025073792-A1 | WRN INHIBITORY COMPOUNDS | FORX THERAPEUTICS AG (CH) | 2025-04-10 | — | — | WO | disclosed |